NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

For the phase III enrollment we have seen some very interesting models by abeta, RK and others. However, the March 7, 2013 guidance for enrollment presented by NWBO still gives me a headache, This guidance states that by the end of Q1 2014 or the beginning of Q2 2014, 312 patients could be enrolled. So, if about 90-100 patients were enrolled by March 7, 2013, NWBO would have had to enroll an additional 212-222 patients by April 30 or let's say by May 31, 2014. Therefore roughly within 4-5 quarters NWBO was planning to enroll about 42-55 patients per quarter (212/5; 222/4). This would seem to me to be a very difficult task. I would very much appreciate any explanation or comments.